Monopar Therapeutics Stock Forecast - Naive Prediction

MNPR Stock  USD 69.60  4.57  7.03%   
The Naive Prediction forecasted value of Monopar Therapeutics on the next trading day is expected to be 71.89 with a mean absolute deviation of 2.31 and the sum of the absolute errors of 140.88. Monopar Stock Forecast is based on your current time horizon. Although Monopar Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Monopar Therapeutics' systematic risk associated with finding meaningful patterns of Monopar Therapeutics fundamentals over time.
As of today the rsi of Monopar Therapeutics' share price is below 20 . This indicates that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Momentum 0

 Sell Peaked

 
Oversold
 
Overbought
The successful prediction of Monopar Therapeutics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Monopar Therapeutics and does not consider all of the tangible or intangible factors available from Monopar Therapeutics' fundamental data. We analyze noise-free headlines and recent hype associated with Monopar Therapeutics, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Monopar Therapeutics' stock price prediction:
EPS Estimate Next Quarter
(0.47)
EPS Estimate Current Year
(1.71)
EPS Estimate Next Year
(3.56)
Wall Street Target Price
112
EPS Estimate Current Quarter
(0.43)
Using Monopar Therapeutics hype-based prediction, you can estimate the value of Monopar Therapeutics from the perspective of Monopar Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.

Monopar Therapeutics Hype to Price Pattern

Investor biases related to Monopar Therapeutics' public news can be used to forecast risks associated with an investment in Monopar. The trend in average sentiment can be used to explain how an investor holding Monopar can time the market purely based on public headlines and social activities around Monopar Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Monopar Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Monopar Therapeutics.
The Naive Prediction forecasted value of Monopar Therapeutics on the next trading day is expected to be 71.89 with a mean absolute deviation of 2.31 and the sum of the absolute errors of 140.88.

Monopar Therapeutics after-hype prediction price

    
  USD 65.01  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Monopar Therapeutics to cross-verify your projections.
To learn how to invest in Monopar Stock, please use our How to Invest in Monopar Therapeutics guide.At this time, Monopar Therapeutics' Liabilities And Stockholders Equity is relatively stable compared to the past year. As of 01/14/2026, Other Current Assets is likely to grow to about 88.6 K, though Net Debt is likely to grow to (39.2 M).

Monopar Therapeutics Additional Predictive Modules

Most predictive techniques to examine Monopar price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Monopar using various technical indicators. When you analyze Monopar charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Monopar Therapeutics Cash Forecast

Forecasting financial indicators like cash flow involves analysts applying various statistical methods, techniques, and algorithms. These tools reveal hidden trends within the Monopar Therapeutics' financial statements to estimate their effects on upcoming price movements.
 
Cash  
First Reported
2016-03-31
Previous Quarter
39.5 M
Current Value
127.7 M
Quarterly Volatility
21.8 M
 
Yuan Drop
 
Covid
A naive forecasting model for Monopar Therapeutics is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Monopar Therapeutics value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Monopar Therapeutics Naive Prediction Price Forecast For the 15th of January 2026

Given 90 days horizon, the Naive Prediction forecasted value of Monopar Therapeutics on the next trading day is expected to be 71.89 with a mean absolute deviation of 2.31, mean absolute percentage error of 9.22, and the sum of the absolute errors of 140.88.
Please note that although there have been many attempts to predict Monopar Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Monopar Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Monopar Therapeutics Stock Forecast Pattern

Backtest Monopar TherapeuticsMonopar Therapeutics Price PredictionBuy or Sell Advice 

Monopar Therapeutics Forecasted Value

In the context of forecasting Monopar Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Monopar Therapeutics' downside and upside margins for the forecasting period are 68.23 and 75.55, respectively. We have considered Monopar Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
69.60
71.89
Expected Value
75.55
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Monopar Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Monopar Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria120.3318
BiasArithmetic mean of the errors None
MADMean absolute deviation2.3096
MAPEMean absolute percentage error0.0298
SAESum of the absolute errors140.8826
This model is not at all useful as a medium-long range forecasting tool of Monopar Therapeutics. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Monopar Therapeutics. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Monopar Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Monopar Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
61.4465.0168.58
Details
Intrinsic
Valuation
LowRealHigh
58.5375.4278.99
Details
5 Analysts
Consensus
LowTargetHigh
101.92112.00124.32
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.49-0.43-0.4
Details

Other Forecasting Options for Monopar Therapeutics

For every potential investor in Monopar, whether a beginner or expert, Monopar Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Monopar Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Monopar. Basic forecasting techniques help filter out the noise by identifying Monopar Therapeutics' price trends.

Monopar Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Monopar Therapeutics stock to make a market-neutral strategy. Peer analysis of Monopar Therapeutics could also be used in its relative valuation, which is a method of valuing Monopar Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Monopar Therapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Monopar Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Monopar Therapeutics' current price.

Monopar Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Monopar Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Monopar Therapeutics shares will generate the highest return on investment. By undertsting and applying Monopar Therapeutics stock market strength indicators, traders can identify Monopar Therapeutics entry and exit signals to maximize returns.

Monopar Therapeutics Risk Indicators

The analysis of Monopar Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Monopar Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting monopar stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Pair Trading with Monopar Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Monopar Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monopar Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Monopar Stock

  0.79LIPO Lipella PharmaceuticalsPairCorr

Moving against Monopar Stock

  0.82ATI Allegheny TechnologiesPairCorr
  0.81BAC Bank of AmericaPairCorr
  0.77ACR-PC ACRES Commercial RealtyPairCorr
  0.77ACN Accenture plcPairCorr
  0.77XOM Exxon Mobil Corp Aggressive PushPairCorr
The ability to find closely correlated positions to Monopar Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Monopar Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Monopar Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Monopar Therapeutics to buy it.
The correlation of Monopar Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Monopar Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Monopar Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Monopar Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Monopar Stock Analysis

When running Monopar Therapeutics' price analysis, check to measure Monopar Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Monopar Therapeutics is operating at the current time. Most of Monopar Therapeutics' value examination focuses on studying past and present price action to predict the probability of Monopar Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Monopar Therapeutics' price. Additionally, you may evaluate how the addition of Monopar Therapeutics to your portfolios can decrease your overall portfolio volatility.